European Equities Traded in the US as American Depositary Move Higher in Monday Trading

MT Newswires Live11-12

European equities traded in the US as American depositary receipts were moving higher late Monday morning, rising 0.35% to 1,339.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma (ASND), which rose 4.8% and 3.3% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and internet advertising firm Criteo (CRTO), which were up 2.9% and 2% respectively.

The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and biotech firm Evaxion Biotech (EVAX), which fell 2.4% and 1.8% respectively. They were followed by medical device maker Edap (EDAP) and telecommunications operator Telefonica (TEF), which were down 1.7% and 1.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and Akari Therapeutics (AKTX), which climbed 6.3% and 5.2% respectively. They were followed by financial services company Barclays (BCS) and software firm Endava (DAVA), which increased 3.6% and 2.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company TC Biopharm (TCBP) and biotech firm Trinity Biotech (TRIB), which lost 5.9% and 3.7% respectively. They were followed by mining company BHP Group (BHP) and biopharmaceutical company Amarin (AMRN), which were off 2.8% and 2.1% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment